Skip to main content

News & Events

News & Announcements

The Daily Record: KaloCyte relocates to Baltimore’s UM BioPark

KaloCyte, a preclinical-stage health care biotechnology company developing a synthetic, bio-inspired red blood cell substitute for use in settings when stored red blood cells are not available, has joined Baltimore’s growing biotech community as a University of Maryland BioPark affiliate.

KaloCyte’s relocation from St. Louis brings it closer to major stakeholders and funders, including the National Institutes of Health National Heart, Lung, and Blood Institute’s Small Business Program and the U.S. Department of Defense Army Combat Casualty Care Research Program, as well as the outstanding research and clinical communities at the University of Maryland, Baltimore and University of Maryland, Baltimore County campuses.

Read the full story from The Daily Record.